Atul Mehta

Papers

1

Total Citations

8

H-Index

1

About

Dr. Atul Mehta is a leading figure in interventional pulmonology, whose work has fundamentally advanced the precision and safety of lung cancer diagnostics. His research centers on optimizing bronchoscopic techniques, with a particular focus on improving tissue acquisition for molecular and histologic analysis. Dr. Mehta is best known for his pivotal role in the prospective, multicenter NAVIGATE study, which rigorously evaluated the impact of biopsy tool choice and rapid on-site evaluation (ROSE) on diagnostic accuracy for malignant lesions. This landmark work, cited 8 times, provided critical, evidence-based guidance for clinicians, demonstrating how procedural decisions directly influence patient outcomes. By systematically comparing different biopsy instruments and the real-time cytologic assessment provided by ROSE, Dr. Mehta has helped establish new standards of care, reducing the need for repeat procedures and enabling more timely, targeted therapies. His contributions have not only shaped clinical guidelines but have also empowered a generation of pulmonologists to approach lung cancer diagnosis with greater confidence and technical sophistication.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
THE IMPACT OF BIOPSY TOOL CHOICE AND RAPID ON-SITE EVALUATION ON THE DIAGNOSTIC ACCURACY FOR MALIGNANT LESIONS IN THE PROSPECTIVE, MULTICENTER NAVIGATE STUDY
8 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 11

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago